Physician profile
John E Jordan
NPI 1174684344
$932.90
in general payments reported to CMS, 2019-2025
16 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.81 · 2020: $21.53 · 2021: $13.08 · 2022: $342 · 2023: $56.06 · 2024: $139 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.06 |
| Education | $177.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $316.31 | 2021-2024 | Nucala, Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $107.75 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Sanofi-Aventis U.S. LLC | $89.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.53 | 2025 | Glassia |
| Mylan Specialty L.P. | $77.07 | 2022-2023 | Yupelri |
| Genzyme Corporation | $53.37 | 2025 | |
| Inspire Medical Systems, INC. | $42.48 | 2025 | Inspire |
| Philips North America LLC | $35.36 | 2020-2025 | Amara Cushions |
| Horizon Therapeutics Plc | $22.51 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $21.33 | 2022 | |
| Pulmonx Corporation | $17.72 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Itamar Medical INC | $15.11 | 2022 | |
| Fisher & Paykel Healthcare INC | $14.21 | 2024 | Fisher & Paykel Healthcare |
| Inogen, INC. | $14.03 | 2025 | |
| Electromed, INC. | $13.82 | 2025 | Smartvest |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.